Rare diseases
Investigational molecules
Locations
Study Comparing ABBV-383 with Standard Therapies for Adults with Relapsed or Refractory Multiple Myeloma
PortugalStudy of Zanubrutinib and Rituximab Compared to Bendamustine and Rituximab for Patients with Untreated Mantle Cell Lymphoma Ineligible for Stem Cell Transplant
PortugalStudy Comparing Pirtobrutinib to Bendamustine and Rituximab for Untreated Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
PortugalStudy on Setrusumab for Patients with Osteogenesis Imperfecta (Brittle Bone Disease)
PortugalStudy of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy
PortugalStudy of Ibrutinib and Rituximab for Patients with Untreated Marginal Zone Lymphoma
PortugalStudy of Trastuzumab Deruxtecan for Patients with HER2-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer After Trastuzumab Treatment
PortugalStudy of TAR-200 and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Not Undergoing Radical Cystectomy
PortugalStudy of Immunotherapy Combinations with GSK4428859, Dostarlimab, and GSK6097608 for Patients with Advanced Non-Small Cell Lung Cancer
PortugalStudy Comparing Crovalimab and Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently on Complement Inhibitors
PortugalStudy of Pembrolizumab, Epacadostat, and Drug Combination for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
PortugalStudy of Disitamab Vedotin and Pembrolizumab for Patients with Untreated Advanced Urothelial Cancer Expressing HER2
PortugalTell us about your condition – we search every trial in Europe and connect you with the right site.
